EUCTR2017-002164-41-ES进行中（未招募）1 期
Growth hormone therapy in adults with Prader-Willi syndrome: Effect on muscle tone assessed by functional magnetic resonance imaging (fMRI) and its relation to muscle strenght and body composition.
Fundació Parc Taulí0 个研究点开始时间: 2017年6月21日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with PWS = 18 years
- •Patients who have demonstrated a GH deficiency in at least one of the
- •two GH stimuli tests performed in routine clinical practice
- •Patients (or their legal guardians if they are legally incapacitated) who
- •have signed informed consent to participate in the study. In the case of
- •patients legally incapacitated, they will give their assent in participating.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Contraindications for MRI
- •Inability to stand still during MRI
- •Impossibility to understand the paradigm to be realized during the MRI
- •Severe obesity, uncontrolled diabetes, severe untreated obstructive
- •sleep apnea, active cancer and active psychosis
- •Patients who present any other contraindication to treatment with GH
- •according to the data sheet.
- •Any circumstance that at the discretion of the physician may pose a
- •risk or clinical harm to the patient's participation in the study or
- •interfere with the assessments of the same.
研究者
相似试验
尚未招募
不适用
Global Growth hormone study in Adults with Prader-Willi SyndromeNL-OMON27149Erasmus Medical Center72
已完成
4 期
GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body CompositionPrader-Willi SyndromeNCT03616509Corporacion Parc Tauli30
进行中（未招募）
不适用
Effects of growth hormone treatment to patients with partial growth hormone deficiency, with special emphasis on acute phase proteins and pro-inflammatory cytokines.EUCTR2005-004478-26-SEKarolinska universitetssjukhuset
已完成
3 期
Growth Hormone Use in Adults With Prader-Willi SyndromePrader-Willi SyndromeNCT00444964Children's Mercy Hospital Kansas City11
进行中（未招募）
不适用
Growth hormone and androgens in the treatment of glucocorticoid induced protein catabolism - GH and androgens in protein catabolismChronic treatment with glucocorticoids (GCs) regardless of indication leads to marked protein catabolism that causes substantial debilitation which includes muscle wasting, weakness, skin fragility, bruising, poor wound healing and osteoporosis. The selection of subjects is therefore patients with polymyalgia rheumatica or inflammatory arthitis receiving long-term GC treatment.EUCTR2005-003750-10-SEVästraGötaland12